Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PAVmed Q2 EPS $(1.19) Beats $(1.45) Estimate, Sales $979.00K Miss $1.20M Estimate

Author: Benzinga Newsdesk | August 13, 2024 08:28am
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.19) per share which beat the analyst consensus estimate of $(1.45) by 17.93 percent. This is a 43.33 percent increase over losses of $(2.10) per share from the same period last year. The company reported quarterly sales of $979.00 thousand which missed the analyst consensus estimate of $1.20 million by 18.42 percent. This is a 489.76 percent increase over sales of $166.00 thousand the same period last year.

Posted In: PAVM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist